NLS bc platforms

Agreement - April 20, 2021

BC Platforms enters new partnership

BC Platforms has announced a new strategic partnership with US-based company TripleBlind  to help drive the development of privacy and intellectual property rights (IPR) preserving “federated AI” for its BCRQUEST.com Global Data Partner Network. The partnership will enhance BCP’s contribution to the Finnish-led PRIVASA (Privacy Preserving AI for Synthetic and Anonymous Health Data) consortium, which […]

Pharma Business - September 13, 2017

BC Platforms launches new data analytic resource

BC Platforms has launched a resource that enables integrated analytics of genomic and clinical data. The resource, BC|RQUEST, facilitates browsing and analytics of genomic and clinical data that has been aggregated across biobanks and streamlines collaboration between biobanks and the pharmaceutical industry.  Microsoft will provide the cloud infrastructure for indexing and accessing the information globally and securely […]

Financing - May 9, 2017

BC Platforms closes a USD $10 million financing round

The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. To date, the company has established partnerships with over 50 enterprise level healthcare units and biobanks globally in 19 countries representing more than 2 million subjects. “We are […]

Agreement - February 13, 2017

BC Platforms enters new partnership

BC Platforms has signed a partnership with Dartmouth-Hitchcock Medical Center’s laboratory of Clinical Genomics and Advanced Technology in the Department of Pathology & Laboratory Medicine in the US, focused on providing data management solutions in cancer research. BC Platforms will link clinical and genomic data from Dartmouth-Hitchcock’s tumour biobank to enable rapid statistical analysis of […]

Agreement - October 19, 2016

BC Platforms, Karolinska extend partnership

BC Platforms announced that the Center for Molecular Medicine (CMM) at the Karolinska Institute has extended its research partnership with them to encompass its newest version of the platform and include its BC|GENOME and BC|TILING tools to add capacity for large scale next generation sequencing as well as superior data handling and analytics. Ingrid Kochum, […]

Agreement - August 8, 2016

BC Platforms signs new partnership

BC Platforms has signed a partnership with Codigo46, an emerging Mexican company, focused on building and managing the largest biobank in Latin-America in co-operation with Mexican health and research specialists to deliver clinical patient benefits and future personalised medicines through academic and commercial research. This biobank, which is unique due to the Mexican genotype which […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.